Molecular diagnostics in cancer patients with suspected respiratory mold infections.

Saved in:
Bibliographic Details
Title: Molecular diagnostics in cancer patients with suspected respiratory mold infections.
Authors: Rickerts V; Robert Koch-Institut, Unit 16: Mycotic and Parasitic Agents and Mycobacteria, Berlin, Germany., Springer J; Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany., Gerkrath J; Robert Koch-Institut, Unit 16: Mycotic and Parasitic Agents and Mycobacteria, Berlin, Germany., Korczynski D; Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Kessel J; Medical Clinic 2, Goethe University Frankfurt, Frankfurt, Hessen, Germany., Wieters I; Medical Clinic 2, Goethe University Frankfurt, Frankfurt, Hessen, Germany.; Robert Koch-Institut, Unit 37: Healthcare-Associated Infections, Surveillance of Antibiotic Resistance and Consumption, Berlin, Germany., Liebregts T; Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Nordrhein Westfalen, Germany., Steinmann J; Institute of Medical Microbiology, Excellence Center for Medical Mycology (ECMM), University Hospital Essen, Essen, Nordrhein Westfalen, Germany.; Institute of Clinical Microbiology, Infectious Diseases and Infection Control, Paracelsus Medical University, Klinikum Nürnberg, Nürnberg, Germany., Cornely OA; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Nordrhein Westfalen, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Cologne, Nordrhein Westfalen, Germany.; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Nordrhein Westfalen, Germany.; Partner Site Bonn-Cologne, German Centre for Infection Research, Cologne, Nordrhein Westfalen, Germany.; Clinical Trials Centre Cologne (ZKS), University Hospital Cologne, University of Cologne, Cologne, Nordrhein Westfalen, Germany., Koehler P; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Nordrhein Westfalen, Germany.; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Nordrhein Westfalen, Germany.; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Division of Clinical Immunology, University of Cologne, Cologne, Nordrhein Westfalen, Germany., Schwartz S; Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany., Elgeti T; Klinik für Radiologie, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Berlin, Germany., Meintker L; Abteilung für Innere Medizin 5, Uniklinikum Erlangen, Erlangen, Bayern, Germany., Krause SW; Abteilung für Innere Medizin 5, Uniklinikum Erlangen, Erlangen, Bayern, Germany., Held J; Mikrobiologisches Institut-Klinische Mikrobiologie Immunologie und Hygiene, Universitätsklinik Erlangen und Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany., Heinz WJ; Medizinische Klinik 2, Caritas Hospital, Bad Mergentheim, Bayern, Germany., Willinger B; Division of Clinical Microbiology, Department for Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Maschmeyer G; Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Brandenburg, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany., Voigt S; Robert Koch-Institut, Unit 12: Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients, Berlin, Germany., Reiche J; Robert Koch-Institut, Unit 17: Influenza and Other Respiratory Viruses, Berlin, Germany., Vehreschild JJ; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Nordrhein Westfalen, Germany., Einsele H; Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany., Teschner D; Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.; Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Löffler J; Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.
Source: Journal of clinical microbiology [J Clin Microbiol] 2025 Dec 17; Vol. 63 (12), pp. e0120125. Date of Electronic Publication: 2025 Nov 26.
Publication Type: Journal Article; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-660X
DOI:10.1128/jcm.01201-25